CA2318664A1 - Nucleotide expression systems with reduced immunogenicity for use in gene therapy - Google Patents
Nucleotide expression systems with reduced immunogenicity for use in gene therapy Download PDFInfo
- Publication number
- CA2318664A1 CA2318664A1 CA002318664A CA2318664A CA2318664A1 CA 2318664 A1 CA2318664 A1 CA 2318664A1 CA 002318664 A CA002318664 A CA 002318664A CA 2318664 A CA2318664 A CA 2318664A CA 2318664 A1 CA2318664 A1 CA 2318664A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- vector
- virus
- cells
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7140998P | 1998-01-14 | 1998-01-14 | |
US60/071,409 | 1998-01-14 | ||
PCT/US1999/000733 WO1999036562A1 (en) | 1998-01-14 | 1999-01-13 | Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2318664A1 true CA2318664A1 (en) | 1999-07-22 |
Family
ID=22101129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002318664A Abandoned CA2318664A1 (en) | 1998-01-14 | 1999-01-13 | Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1045920A1 (ja) |
JP (1) | JP2002508976A (ja) |
AU (1) | AU2114899A (ja) |
CA (1) | CA2318664A1 (ja) |
WO (1) | WO1999036562A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10019195B4 (de) * | 2000-04-17 | 2006-03-09 | Heart Biosystems Gmbh | Reversible Immortalisierung |
AUPQ811700A0 (en) * | 2000-06-13 | 2000-07-06 | Crc Pest Animal Control | Biological control agent |
CA2420944A1 (en) | 2000-08-30 | 2002-03-07 | Chemocentryx, Inc. | Inhibition of cmv infection and dissemination |
AU2002242085A1 (en) | 2001-02-02 | 2002-08-19 | Chemocentryx, Inc. | Methods and compositions useful for stimulating an immune response |
JP7273840B2 (ja) * | 2018-03-19 | 2023-05-15 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | 不活性化ul18および/またはul8を有する新しいehv |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750398A (en) * | 1993-11-30 | 1998-05-12 | David C. Johnson | Vector, element and method for inhibiting immune recognition |
US5846806A (en) * | 1994-07-29 | 1998-12-08 | American Cyanamid Company | Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression |
KR19980703665A (ko) * | 1995-04-04 | 1998-12-05 | 카렌 크루벤 | 세포 표면상 제 1 류 mhc 단백질의 수준이 낮은 유전적으로변형된 세포의 이식 |
US5891857A (en) * | 1996-02-20 | 1999-04-06 | Vanderbilt University | Characterized BRCA1 and BRCA2 proteins and screening and therapeutic methods based on characterized BRCA1 and BRCA2 proteins |
-
1999
- 1999-01-13 EP EP99901457A patent/EP1045920A1/en not_active Withdrawn
- 1999-01-13 AU AU21148/99A patent/AU2114899A/en not_active Abandoned
- 1999-01-13 JP JP2000540263A patent/JP2002508976A/ja active Pending
- 1999-01-13 CA CA002318664A patent/CA2318664A1/en not_active Abandoned
- 1999-01-13 WO PCT/US1999/000733 patent/WO1999036562A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1045920A1 (en) | 2000-10-25 |
WO1999036562A1 (en) | 1999-07-22 |
AU2114899A (en) | 1999-08-02 |
JP2002508976A (ja) | 2002-03-26 |
WO1999036562A9 (en) | 1999-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102319845B1 (ko) | 조류 숙주 세포에 대한 crispr-cas 시스템 | |
AU2018229561B2 (en) | Recombinant adenoviruses and use thereof | |
KR102609858B1 (ko) | 점액다당류증의 치료를 위한 아데노-관련 바이러스 벡터 | |
CN111295449B (zh) | 腺病毒载体及其用途 | |
ES2388527T3 (es) | Vacunas de VIH basadas en Env de múltiples clados de VIH | |
AU2016317936A1 (en) | Recombinant vectors comprising 2A peptide | |
CA2776272C (en) | Development of a preventive vaccine for filovirus infection in primates | |
KR102494564B1 (ko) | 말라리아 백신 | |
US20220056475A1 (en) | Recombinant poxviruses for cancer immunotherapy | |
KR20110039258A (ko) | 개선된 단백질 발현계 | |
CN112534047A (zh) | 经修饰的t细胞及其用途 | |
CN113396222A (zh) | 腺相关病毒(aav)生产细胞系和相关方法 | |
KR20210105382A (ko) | 단백질을 코딩하는 rna | |
KR20220121844A (ko) | 유전자의 발현을 동시에 조절하기 위한 조성물 및 방법 | |
KR20220084282A (ko) | Ipsc로부터의 피질 신경 전구 세포 | |
JP2024037917A (ja) | 組換えt細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 | |
CN115927299A (zh) | 增加双链rna产生的方法和组合物 | |
KR20200083510A (ko) | 아데노바이러스 및 이의 용도 | |
CN114026242A (zh) | 具有髓鞘蛋白零启动子的aav载体及其用于治疗雪旺细胞相关疾病如charcot-marie-tooth疾病的用途 | |
KR102055215B1 (ko) | 돼지 써코바이러스 2형 캡시드 단백질 및 이를 포함하는 약학적 조성물의 제조 방법 | |
JP2024037797A (ja) | がんを処置するための感染性核酸の使用 | |
CA2318664A1 (en) | Nucleotide expression systems with reduced immunogenicity for use in gene therapy | |
KR20240021906A (ko) | 발현 벡터, 박테리아 서열-무함유 벡터, 및 이를 제조하고 사용하는 방법 | |
TW202309288A (zh) | 調節基因表現之組合物及方法 | |
CN113677800A (zh) | 包含用于结合结构域和可分泌肽的基因的重组载体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |